1,25-dihydroxyvitamin D3 and retonic acid analogues induce differentiation in breast cancer cells with function- and cell-specific additive effects

This publication has 40 references indexed in Scilit:

• Effects of vitamin D and retinoids on the differentiation and growth in vitro of canine osteosarcoma and its clonal cell lines
  Research in Veterinary Science, 1999
• Induction of Androgen Receptor by 1α,25-Dihydroxyvitamin D₃and 9-cis Retinoic Acid in LNCaP Human Prostate Cancer Cells¹
  Endocrinology, 1999
• Synergistic inhibition of prostate cancer cell lines by a 19- nor hexafluoride vitamin D3 analogue and anti-activator protein 1 retinoid
  British Journal of Cancer, 1998
• 1,25-Dihydroxyvitamin D3 and 9-cis-Retinoic Acid Act Synergistically to Inhibit the Growth of LNCaP Prostate Cells and Cause Accumulation of Cells in G1*
  Endocrinology, 1997
• Growth-inhibitory effects of vitamin D analogues and retinoids on human pancreatic cancer cells
  British Journal of Cancer, 1996
• EB 1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells
  The Journal of Steroid Biochemistry and Molecular Biology, 1993
• Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling
  Nature, 1992
• Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors
  Nature, 1992
• RXRβ: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements
  Cell, 1991
• Nuclear receptors enhance our understanding of transcription regulation
  Trends in Genetics, 1988